Whole Network Gene Therapy Microbiology Nanomedicine Stem Cells

 

NRP104: Novel Drug Candidate Against Attention Deficit Hyperactivity Disorder (ADHD)

Filed in archive Drugs, Vaccines and Therapeutics by ruth on November 23, 2005

BlogPicture

Attention deficit hyperactivity disorder (ADHD) is a condition that, according to Frost and Sullivan, is projected to afflict about 6.5 million by 2009, the treatment of which will generate a potential revenue of about $3 billion. With patents on adderalllinks, a drug indicated for ADHD, expiring soon, manufacturer Shire teams up with New River Pharmaceuticals to offer alternative solution.

NRP104, New River Pharma's product candidate, is a conditionally bioreversible derivative (CBD) of amphetamine, a stimulant widely used to treat ADHD. NRP104 is intended to provide better overdose protection and a reduced potential for addiction than currently-marketed amphetamine products.

A second, long-term Phase III efficacy and safety study is ongoing, and the producers anticipate filing for an NDA on NRP104 by the end of 2005. The treatment may be ready for commercialization in about a year.

Source: Washington Business Journal






Permalink: NRP104: Novel Drug Candidate Against Attention Deficit Hyperactivity Disorder (ADHD)
Tags: ADHD  amphetamine  adhd  biotech  nrp104  hyperactivity+disorder  deficit+hyperactivity  disorder+adhd 

Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/11368





RSSrss   | See all blog subscribe options
Google google   |   What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter
Grouptivity

Use the search to look for other interesting posts



 
  • Advertise with us

  • Learn more about our advertising options or email advertising - at - creative-weblogging.com or give us a call at +1 (650) 331 4900.


  • Testimonials

  • 'Very nice blog layout with great content. Are you interested in Star Trek props that are quickly becoming reality? Then this is the blog for you. Human medical scanners, nano technology and more great technological advancements.' -VirtualLoop Blog of the Week

    'I subscribe to your blog and have been enjoying your posts and perspective.'


  • Other blogs in the same channel in the Creative Weblogging Network







 

Tagcloud: Biotech Hubs and Facilities Biotech/Science Blogs Corporate and Industrial News Diagnostics, Methodologies and Instrumentation Drugs, Vaccines and Therapeutics Energy, Environment and Ecology Food and Agriculture Gene Therapy Genomics, Proteomics and Bioinformatics Meetings and Other Events Microbiology Nanomedicine Other Biotechnology News Patents and Intellectual Property Rights Sponsored Post Stem Cells